Evidence map›Paper›PMID 34685582›Full record

ArticleCells2021

Adipose Tissue Steroid Receptor RNA Activator 1 (SRA1) Expression Is Associated with Obesity, Insulin Resistance, and Inflammation.

Shihab Kochumon, Hossein Arefanian, Sardar Sindhu, Steve Shenouda, Reeby Thomas, Fahd Al-Mulla, Jaakko Tuomilehto, Rasheed Ahmad

Open access · goldAbstract read
In one paragraph

Article in Cells, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Long Noncoding RNAs in the Pathogenesis of Insulin Resistance.International journal of molecular sciences · 2022
    Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 3 countries.

Shihab KochumonDepartment of Immunology & Microbiology, Dasman Diabetes Institute, Dasman 15462, Kuwait.
Hossein ArefanianDepartment of Immunology & Microbiology, Dasman Diabetes Institute, Dasman 15462, Kuwait.ORCID 0000-0001-6414-0916
Sardar SindhuAnimal and Imaging Core Facilities, Dasman Diabetes Institute, Dasman 15462, Kuwait.ORCID 0000-0001-9936-1575
Steve ShenoudaDepartment of Immunology & Microbiology, Dasman Diabetes Institute, Dasman 15462, Kuwait.
Reeby ThomasDepartment of Immunology & Microbiology, Dasman Diabetes Institute, Dasman 15462, Kuwait.
Fahd Al-MullaDepartment of Genetics and Bioinformatics, Dasman Diabetes Institute, Dasman 15462, Kuwait.ORCID 0000-0001-5409-3829
Jaakko TuomilehtoDepartment of Public Health, University of Helsinki, 00100 Helsinki, Finland.
Rasheed AhmadDepartment of Immunology & Microbiology, Dasman Diabetes Institute, Dasman 15462, Kuwait.ORCID 0000-0001-5746-0743
Dasman Diabetes Institute · KWUniversity of Helsinki · FI

Funding

Kuwait Foundation for the Advancement of Sciences RA-2010-003
6 · The paper itself

Abstract

Steroid receptor RNA activator 1 (

Indexed as

Adipose TissueBiomarkersCarrier ProteinsDiabetes Mellitus, Type 2FemaleHumansInflammationInsulin ResistanceMaleMiddle AgedObesityBiomarkersCarrier Proteinssteroid receptor RNA activator, humanadipose tissueinflammationinsulin resistanceobesitysteroid receptor RNA activator 1/SRA1type 2 diabetes

Identifiers

PMID34685582
PMCPMC8534244
OpenAlexW3202227068

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.